Lunai Bioworks (LNAI) Retained Earnings (2011 - 2026)
Lunai Bioworks (LNAI) posted quarterly Retained Earnings of -$155698.0 for Q1 2026, up 99.96% year-over-year from -$77864.8 in Q1 2025, and down 11.99% quarter-over-quarter from -$139023.0 in Q4 2025.
Lunai Bioworks (LNAI) Retained Earnings (2011 - 2026) Analysis & Trends
Lunai Bioworks' Retained Earnings history runs 16 years deep, the most recent figure standing at -$155698.0 for Q1 2026.
- In Q1 2026, Retained Earnings rose 99.96% year-over-year to -$155698.0; the TTM figure through Mar 2026 stood at -$155698.0 (up 99.96% YoY), while the FY2025 annual figure was $478.3 million, up 280057.45% from the prior year.
- Retained Earnings for Q1 2026 stood at -$155698.0, down from -$139023.0 in the prior quarter.
- The five-year high for Retained Earnings was $494.7 million in Q3 2025, with the low at -$383.7 million in Q1 2025.
- The 5-year median for Retained Earnings is -$139023.0 (2025), against an average of $68.1 million.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings jumped 1506327.16% in 2022, then plunged 1027307.65% in 2023.
- Lunai Bioworks' Retained Earnings stood at $283.4 million in 2022, then sank by 190.93% to -$257.7 million in 2023, then soared by 98.51% to -$3.8 million in 2024, then jumped by 96.39% to -$139023.0 in 2025, then fell by 11.99% to -$155698.0 in 2026.
- Business Quant data shows LNAI's Retained Earnings at -$155698.0 in Q1 2026, -$139023.0 in Q4 2025, and $494.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | 4.38 Bn |
| 10 | Lunai Bioworks | 6.94 Mn | 3.78 Mn | 20,942.00 | -512.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -155,698.00 |
| Dec 31, 2025 | -139,023.00 |
| Sep 30, 2025 | 494.73 Mn |
| Jun 30, 2025 | 478.30 Mn |
| Mar 31, 2025 | -383.73 Mn |
| Dec 31, 2024 | -3.85 Mn |
| Sep 30, 2024 | 468.44 Mn |
| Jun 30, 2024 | -170,846.00 |
| Mar 31, 2024 | -316.72 Mn |
| Dec 31, 2023 | -257.73 Mn |
| Sep 30, 2023 | 300.01 Mn |
| Jun 30, 2023 | -244.03 Mn |
| Mar 31, 2023 | -220.83 Mn |
| Dec 31, 2022 | 283.43 Mn |
| Sep 30, 2022 | 282.40 Mn |
| Jun 30, 2022 | 276.99 Mn |
| Mar 31, 2022 | -21,494.00 |
| Dec 31, 2021 | -18,817.00 |
| Sep 30, 2021 | -101.32 Mn |
| Jun 30, 2021 | -90.91 Mn |